Study Stopped
Business Decision
IVUS-Guided Treatment for Percutaneous Vascular Interventions
IGT-PVI
1 other identifier
observational
5,000
1 country
5
Brief Summary
The main objective of the study is to survey and improve the IVUS image quality and X-ray system interoperability by collecting Procedural Data (e.g. raw, pre- processed ultrasound and X-ray data, endpoints such as fluoroscopy time, contrast load and radiation dose, workflow details) during routine intravascular procedures to assure adherence to the high standards of quality during care delivery and promote procedural standardization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2023
CompletedFirst Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
May 31, 2025
May 1, 2025
4.4 years
December 18, 2023
May 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Improve
Analyze IVUS images for improvement using manual and automated visualization
Procedure (one visit)
Secondary Outcomes (3)
Procedural IVUS TIME
Procedure (one visit)
PROCEDURAL RADIATION DOSE
Procedure (one visit)
PROCEDURAL AMOUNT OF CONTRAST USED
Procedure (one visit)
Study Arms (1)
IVUS GUIDED
Those undergoing an already planned IVUS guided treatment for percutaneous vascular interventions
Interventions
Those already undergoing an IVUS guided percutaneous vascular intervention
Eligibility Criteria
All comers aged 18 and older scheduled to undergo a percutaneous vascular intervention.
You may qualify if:
- The Patient is ≥18 years of age.
- Patient is scheduled to undergo percutaneous vascular intervention - peripheral vascular or coronary PCI procedure.
You may not qualify if:
- Patients not meeting the instructions for use (IFU) of the respective IVUS catheters.
- Patients with lesions or vessel segments deemed unsafe for multiple IVUS pullbacks.
- Patients who are pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Southwest Cardiovascular Associates
Mesa, Arizona, 85208, United States
Pulse Cardiovascular
Scottsdale, Arizona, 85251, United States
Center for Advanced Cardiac and Vascular Interventions
Tarzana, California, 91356, United States
Pacific Cardiovascular and Vein Institute
Ventura, California, 93003, United States
Community Healthcare System
Munster, Indiana, 46321, United States
Study Officials
- STUDY CHAIR
Eric Secemsky, MD
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2023
First Posted
February 2, 2024
Study Start
September 14, 2023
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
May 31, 2025
Record last verified: 2025-05